Arnauld Verschuur, Marie-Améli, Philippe Dory-Lautrec, Romain Truillet, Elisabeth Jouve, Pascal Chastagner, . . . Nicolas André. (2018). Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial. Frontiers Media S.A..
Chicago Style (17th ed.) CitationArnauld Verschuur, et al. Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial. Frontiers Media S.A., 2018.
MLA (9th ed.) CitationArnauld Verschuur, et al. Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial. Frontiers Media S.A., 2018.
Warning: These citations may not always be 100% accurate.